Staphylococcus Aureus Bacteria | List of Frontiers open access articles

Original Research

Published on 22 May 2019

Microbicidal Phagocytosis of Nucleus Pulposus Cells Against Staphylococcus aureus via the TLR2/MAPKs Signaling Pathway

in Microbial Immunology

Yazhou Lin
Hui Cong
Kewei Liu
Yucheng Jiao
Ye Yuan
Guoqing Tang
Yong Chen
Yuehuan Zheng
Jiaqi Xiao
Changwei Li

Frontiers in Immunology

doi 10.3389/fimmu.2019.01132

5,505 views
12 citations

Original Research

Published on 01 Jul 2022

Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model

in Bacteria and Host

Yu Okae
Kohei Nishitani
Akio Sakamoto
Toshiyuki Kawai
Takuya Tomizawa
Motoo Saito
Yutaka Kuroda
Shuichi Matsuda

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.896978

16,438 views
50 citations

Mini Review

Published on 14 Jan 2021

Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review

in Antimicrobials, Resistance and Chemotherapy

Caleb A. Ford
Ian M. Hurford
James E. Cassat

Frontiers in Microbiology

doi 10.3389/fmicb.2020.632706

23,104 views
106 citations

Original Research

Published on 24 Jun 2021

The Recombinant Expression Proteins FnBP and ClfA From Staphylococcus aureus in Addition to GapC and Sip From Streptococcus agalactiae Can Protect BALB/c Mice From Bacterial Infection

in Veterinary Infectious Diseases

Zhongchen Ma
Xinyue Yin
Peng Wu
Ruirui Hu
Yong Wang
Jihai Yi
Zhen Wang
Chuangfu Chen

Frontiers in Veterinary Science

doi 10.3389/fvets.2021.666098

5,927 views
6 citations

Original Research

Published on 27 Feb 2024

Hospital antimicrobial stewardship: profiling the oral microbiome after exposure to COVID-19 and antibiotics

in Infectious Agents and Disease

Patricia Buendia
Krystal Fernandez
Castle Raley
Ali Rahnavard
Keith A. Crandall
Jose Guillermo Castro

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1346762

5,339 views
3 citations

Original Research

Published on 15 Oct 2019

Balsacone C, a New Antibiotic Targeting Bacterial Cell Membranes, Inhibits Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA) Without Inducing Resistance

in Antimicrobials, Resistance and Chemotherapy

Héloïse Côté
André Pichette
François Simard
Marie-Eve Ouellette
Lionel Ripoll
Mouadh Mihoub
Doria Grimard
Jean Legault

Frontiers in Microbiology

doi 10.3389/fmicb.2019.02341

12,086 views
27 citations

Articles

Microbicidal Phagocytosis of Nucleus Pulposus Cells Against Staphylococcus aureus via the TLR2/MAPKs Signaling Pathway

Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model

Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review

The Recombinant Expression Proteins FnBP and ClfA From Staphylococcus aureus in Addition to GapC and Sip From Streptococcus agalactiae Can Protect BALB/c Mice From Bacterial Infection

Hospital antimicrobial stewardship: profiling the oral microbiome after exposure to COVID-19 and antibiotics

Balsacone C, a New Antibiotic Targeting Bacterial Cell Membranes, Inhibits Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA) Without Inducing Resistance